3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
43
Carcinoma, Non-Small-Cell Lung
35
Breast Neoplasms
35
Triple Negative Breast Neoplasms
16
Neoplasms
15
Neoplasm Metastasis
14
Carcinoma
9
Adenocarcinoma
9
Lung Neoplasms
7
Head and Neck Neoplasms
6
Colorectal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Pancreatic Diseases
5
Cholangiocarcinoma
5
Carcinoma, Squamous Cell
5
Neoplasms by Site
4
Melanoma
4
Digestive System Neoplasms
4
Digestive System Diseases
4
Sarcoma
3
Pancreatic Adenocarcinoma
3
Neoplasms by Histologic Type
3
Inflammatory Breast Neoplasms
3
Endocrine System Diseases
3
Endocrine Gland Neoplasms
3
Carcinoma, Pancreatic Ductal
3
Carcinoma, Ovarian Epithelial
3
Uveal Melanoma
2
Urinary Bladder Neoplasms
2
Interventions
Rituximab
155
Cyclophosphamide
120
fludarabine phosphate
71
Whole-Body Irradiation
55
Mycophenolic Acid
54
Etoposide
53
Peripheral Blood Stem Cell Transplantation
46
fludarabine
45
Melphalan
44
Granulocyte Colony-Stimulating Factor
43
Busulfan
43
Tacrolimus
39
Filgrastim
37
Vincristine
33
Cyclosporine
31
Bendamustine Hydrochloride
31
Prednisone
29
Doxorubicin
29
Antilymphocyte Serum
28
Methotrexate
27
Cytarabine
27
Lenalidomide
23
Carmustine
22
Bortezomib
22
plerixafor
20
Dexamethasone
19
Thiotepa
17
Stem Cell Transplantation
17
Radiotherapy
17
tositumomab I-131
16
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Non-Hodgkin
×
130-nm albumin-bound paclitaxel
×
Clear all
No trials found.